YOLFTbeta
Cann Group Ltd

Cann Group Ltd

CAN · AU · Healthcare / Drug Manufacturers - Specialty & Generic

0.005AUD-0.00 (-9.09%)

Price History

Full chart

Market Stats

Previous Close0.0055
Open0.005
Day Range0.005 – 0.0055
52-Week Range0.002 – 0.017
Volume1.03M
Market Cap7.47M
P/E (TTM)0.23
Forward P/E0.00
EPS0.02
Dividend Yield0.00%
Beta0.11
50-Day Avg0.0039
200-Day Avg0.0056

About

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivation, manufacture, and sale of medicinal cannabis in Australia and Europe. Its product portfolio includes the Satipharm delivery system for cannabinoids. The company was founded in 2014 and is based in Mildura, Australia.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Michael Joseph Ryan
  • Employees0
  • Headquarters23 Greentek Court, Mildura, VIC, Australia, 3501, Australia
  • Websitehttps://www.canngrouplimited.com

Leadership

  • Mr. Michael Joseph RyanInterim Executive Chairman
  • Mr. Steven Notaro BA, J.D.Head of Legal and Regulatory Affairs & Company Secretary

Financials

Income Statement

Currency: AUD2015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue13.74K6.66K8.42K605.65K2.61M647.22K4.29M6.41M13.78M15.37M13.25M8.56M
Growth (%)--51.52%+26.40%+7092.09%+330.60%-75.18%+563.30%+49.34%+114.90%+11.58%-13.79%-35.39%
Cost of Revenue028.92K124.30K104.82K465.92K641.00K48.00K-4.83M-6.86M37.13M8.10M16.62M
Gross Profit13.74K-22.25K-115.88K500.83K2.14M6.22K4.25M11.24M20.63M-21.75M5.15M-8.06M
Gross Margin100.00%-334.06%-1376.04%82.69%82.13%0.96%98.88%175.29%149.77%-141.51%38.88%-94.13%
Operating Expense4.18M1.41M2.07M6.12M14.51M16.65M27.74M40.31M57.89M5.75M14.10M3.96M
Operating Income-4.16M-1.43M-2.19M-5.62M-12.37M-16.64M-23.50M-29.07M-37.25M-27.50M-8.94M-12.02M
Operating Margin-30300.47%-21466.08%-26004.99%-927.15%-474.40%-2571.51%-547.33%-453.50%-270.41%-178.89%-67.47%-140.35%
EBITDA-12.55K-1.42M-2.46M-3.87M-9.51M-13.91M-22.55M-24.36M-24.63M-35.54M-8.94M-6.16M
EBITDA Margin-91.36%-21278.31%-29255.43%-639.10%-364.65%-2148.93%-525.39%-380.02%-178.75%-231.16%-67.46%-71.95%
Net Income-4.18M-1.46M-2.59M-4.73M-10.93M-16.94M-25.10M-26.47M-33.79M-51.24M-22.34M20.30M
Net Income Margin-30391.84%-21945.53%-30737.98%-780.30%-418.96%-2616.94%-584.74%-412.85%-245.26%-333.32%-168.60%237.11%
R&D437.39K64.40K547.78K776.43K1.05M1.28M2.03M2.99M4.29M755.00K781.00K41.00K
R&D as % of Total Revenue3182.89%966.74%6504.95%128.20%40.17%198.25%47.31%46.65%31.13%4.91%5.89%0.48%
Interest Expense12.55K15.53K5498.38K198.91K869.03K4.15M1.83M3.16M6.82M6.00M5.12M
Interest Expense % of Total Revenue91.35%233.16%6.52%1.38%7.63%134.27%96.69%28.51%22.92%44.36%45.25%59.82%

Balance Sheet

Currency: AUD2015-06-302016-06-302016-12-312017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets726.15K1.87M15.89M15.07M86.80M82.11M76.40M101.79M139.66M129.47M92.77M78.79M51.99M
Total Liabilities77.83K181.85K159.71K413.87K927.67K4.82M15.33M9.92M54.76M70.20M78.85M81.56M23.39M
Total Equity648.33K1.69M15.73M14.66M85.87M77.30M61.07M91.87M84.90M59.26M13.92M-2.77M28.61M
Cash450.82K1.34M15.23M11.11M49.57M46.39M1.55M3.10M1.91M765.00K1.64M10.00K490.00K
Total Debt---24.77K20.57K9.32M9.32M680.00K47.16M60.97M72.47M75.84M16.84M
Net Debt-450.82K-1.34M--11.09M-49.55M-46.39M7.77M-2.42M45.25M60.20M70.83M75.83M16.35M

Cash Flow

Currency: AUD2015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow-642.74K-1.25M-2.30M-3.75M-7.42M-17.62M-20.83M-20.43M-22.84M-15.19M-9.64M-1.33M
Investing Cash Flow-411.29K-379.31K-3.38M-32.69M3.50M-34.36M-17.08M-45.16M-28.00K1.18M-157.00K-406.00K
Financing Cash Flow2.14M2.52M15.45M74.89M740.00K7.15M39.47M64.41M21.71M14.77M8.17M2.22M
Capital Expenditure411.29K344.31K329.45K5.60M25.38M34.36M16.27M45.16M3.10M2.50M157.00K406.00K
Free Cash Flow-1.05M-1.59M-2.63M-9.36M-32.80M-51.98M-37.10M-65.60M-25.94M-17.69M-9.80M-1.74M
FCF to OCF163.99%127.62%114.33%249.27%441.91%295.04%178.11%321.03%113.58%116.50%101.63%130.53%

Earnings

Report DateMay 3, 2017Aug 29, 2017Feb 6, 2018Aug 22, 2018Feb 17, 2019May 29, 2019Aug 27, 2019Nov 27, 2019Feb 25, 2020Jun 3, 2020Aug 26, 2020Dec 2, 2020Feb 21, 2021Jun 2, 2021Aug 22, 2021Dec 1, 2021Feb 16, 2022Jun 1, 2022Aug 29, 2022Oct 27, 2022Feb 28, 2023Apr 27, 2023Aug 28, 2023Oct 31, 2023Feb 29, 2024May 29, 2024Aug 30, 2024Nov 27, 2024Feb 28, 2025May 28, 2025Aug 28, 2025Dec 3, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.00-0.000.000.00-0.00-0.00-0.00-0.000.000.000.000.000.000.000.000.00-0.00
EPS Actual-0.01-0.02-0.01-0.02-0.040.00-0.040.00-0.060.00-0.060.00-0.050.00-0.050.00-0.030.00-0.050.00-0.050.000.000.000.000.000.000.00-0.020.00-0.020.00
Surprise--------------------------------
Timing------------------Pre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-market------Pre-market-

Key Statistics & Ratios

Market Cap7.47M
Enterprise Value22.54M
Trailing P/E0.23
Forward P/E0.00
Price / Sales0.77
Price / Book0.23
EPS0.02
Book Value0.018
Revenue (TTM)9.65M
Gross Profit (TTM)5.99M
EBITDA-4.85M
Profit Margin213.66%
Operating Margin-91.54%
Return on Equity157.35%
Return on Assets-10.23%
Shares Outstanding1.66B
Shares Float1.51B
Beta0.11
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
3.60%
Insiders
21.98%
Retail / Other
74.42%

Top Fund Holders

  • Global X Fds-The Global X Cannabis ETF
    8.11M2.92%